Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Monahan

Showing results (81-90 of 128) with videos related to

Pageof 13
Sort By:
Gene Therapy|October 27, 2006
Transgene expression levels and kinetics determine risk of humoral immune response modeled in factor IX knockout and missense mutant miceT-P Zhang, D-Y Jin, R M Wardrop, et al.
Gene Therapy|April 16, 1998
Direct intramuscular injection with recombinant AAV vectors results in sustained expression in a dog model of hemophiliaP E Monahan, R J Samulski, J Tazelaar, et al.
Journal of Virology|May 18, 2012
Single amino acid modification of adeno-associated virus capsid changes transduction and humoral immune profilesChengwen Li, Nina Diprimio, Dawn E Bowles, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1983
Isolation and characterization of the gene coding for cytosolic phosphoenolpyruvate carboxykinase (GTP) from the ratH Yoo-Warren, J E Monahan, J Short, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 26, 2012
Consequences of intra-articular bleeding in haemophilia: science to clinical practice and beyondA L Forsyth, G-É Rivard, L A Valentino, et al.
Scientific Reports|October 10, 2019
Hemophilia A and B mice, but not VWF<sup>-/-</sup>mice, display bone defects in congenital development and remodeling after injurySarah Taves, Junjiang Sun, Eric W Livingston, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 27, 2017
Recombinant porcine factor VIII for high-risk surgery in paediatric congenital haemophilia A with high-titre inhibitorS E Croteau, Y L Abajas, A S Wolberg, et al.
Journal of Thrombosis and Haemostasis : JTH|June 1, 2019
Prophylactic administration of glycoPEGylated factor IX provides protection and joint outcome superior to recombinant factor IX after induced joint bleedingJunjiang Sun, Eric W Livingston, Mie L Broberg, et al.
Blood|January 1, 2017
Abnormal joint and bone wound healing in hemophilia mice is improved by extending factor IX activity after hemarthrosisJunjiang Sun, Baolai Hua, Eric W Livingston, et al.
Cancer Reports (Hoboken, N.J.)|July 8, 2026
N<sup>w</sup>-Hydroxy L-Arginine (NOHA): A Promising Biomarker of Response to Neoadjuvant Therapy in the Management of Triple Negative Breast CancerSrinidi Mohan, Douglas W Van Pelt, Jamie G Saunders, et al.
Pageof 13

Showing results (81-90 of 128) with videos related to

Sort By:
Pageof 13
Gene Therapy|October 27, 2006
Transgene expression levels and kinetics determine risk of humoral immune response modeled in factor IX knockout and missense mutant miceT-P Zhang, D-Y Jin, R M Wardrop, et al.
Gene Therapy|April 16, 1998
Direct intramuscular injection with recombinant AAV vectors results in sustained expression in a dog model of hemophiliaP E Monahan, R J Samulski, J Tazelaar, et al.
Journal of Virology|May 18, 2012
Single amino acid modification of adeno-associated virus capsid changes transduction and humoral immune profilesChengwen Li, Nina Diprimio, Dawn E Bowles, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1983
Isolation and characterization of the gene coding for cytosolic phosphoenolpyruvate carboxykinase (GTP) from the ratH Yoo-Warren, J E Monahan, J Short, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 26, 2012
Consequences of intra-articular bleeding in haemophilia: science to clinical practice and beyondA L Forsyth, G-É Rivard, L A Valentino, et al.
Scientific Reports|October 10, 2019
Hemophilia A and B mice, but not VWF<sup>-/-</sup>mice, display bone defects in congenital development and remodeling after injurySarah Taves, Junjiang Sun, Eric W Livingston, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 27, 2017
Recombinant porcine factor VIII for high-risk surgery in paediatric congenital haemophilia A with high-titre inhibitorS E Croteau, Y L Abajas, A S Wolberg, et al.
Journal of Thrombosis and Haemostasis : JTH|June 1, 2019
Prophylactic administration of glycoPEGylated factor IX provides protection and joint outcome superior to recombinant factor IX after induced joint bleedingJunjiang Sun, Eric W Livingston, Mie L Broberg, et al.
Blood|January 1, 2017
Abnormal joint and bone wound healing in hemophilia mice is improved by extending factor IX activity after hemarthrosisJunjiang Sun, Baolai Hua, Eric W Livingston, et al.
Cancer Reports (Hoboken, N.J.)|July 8, 2026
N<sup>w</sup>-Hydroxy L-Arginine (NOHA): A Promising Biomarker of Response to Neoadjuvant Therapy in the Management of Triple Negative Breast CancerSrinidi Mohan, Douglas W Van Pelt, Jamie G Saunders, et al.
Pageof 13